plasmodium falciparum chimeric prot. 2.9
Vaccineexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2006 (NCT00284973)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Plasmodium falciparumImmunity, active
Plasmodium falciparum immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- plasmodium falciparum chimeric prot. 2.9
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00284973 | Phase 1 | Jan 1, 2006 | Jiao Tong University, PATH, People's Liberation Army of China, Shanghai Wanxing Bio-Pharmaceutical Co. Ltd., World Health Organization |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiao Tong University | Academic/Hospital | 1 | 0 | 1 | 2006 |
| PATH | Academic/Hospital | 1 | 0 | 1 | 2006 |
| People's Liberation Army of China | Government | 1 | 0 | 1 | 2006 |
| Shanghai Wanxing Bio-Pharmaceutical Co. Ltd. | For profit | 1 | 1 | 1 | 2006 |
| World Health Organization | Government | 1 | 0 | 1 | 2006 |
5 organizations
Page 1 / 1